Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by deployment
1.4.2. Market size breakdown, by end user
1.4.3. Market size breakdown, by application
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Global Market
6.1. Overview
6.2. Market Revenue, by Deployment (2017–2030)
6.3. Market Revenue, by End User (2017–2030)
6.4. Market Revenue, by Application (2017–2030)
6.5. Market Revenue, by Region (2017–2030)
Chapter 7. North America Market
7.1. Overview
7.2. Market Revenue, by Deployment (2017–2030)
7.3. Market Revenue, by End User (2017–2030)
7.4. Market Revenue, by Application (2017–2030)
7.5. Market Revenue, by Country (2017–2030)
Chapter 8. Europe Market
8.1. Overview
8.2. Market Revenue, by Deployment (2017–2030)
8.3. Market Revenue, by End User (2017–2030)
8.4. Market Revenue, by Application (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. APAC Market
9.1. Overview
9.2. Market Revenue, by Deployment (2017–2030)
9.3. Market Revenue, by End User (2017–2030)
9.4. Market Revenue, by Application (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. LATAM Market
10.1. Overview
10.2. Market Revenue, by Deployment (2017–2030)
10.3. Market Revenue, by End User (2017–2030)
10.4. Market Revenue, by Application (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. MEA Market
11.1. Overview
11.2. Market Revenue, by Deployment (2017–2030)
11.3. Market Revenue, by End User (2017–2030)
11.4. Market Revenue, by Application (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. U.S. Market
12.1. Overview
12.2. Market Revenue, by Deployment (2017–2030)
12.3. Market Revenue, by End User (2017–2030)
12.4. Market Revenue, by Application (2017–2030)
Chapter 13. Canada Market
13.1. Overview
13.2. Market Revenue, by Deployment (2017–2030)
13.3. Market Revenue, by End User (2017–2030)
13.4. Market Revenue, by Application (2017–2030)
Chapter 14. Germany Market
14.1. Overview
14.2. Market Revenue, by Deployment (2017–2030)
14.3. Market Revenue, by End User (2017–2030)
14.4. Market Revenue, by Application (2017–2030)
Chapter 15. France Market
15.1. Overview
15.2. Market Revenue, by Deployment (2017–2030)
15.3. Market Revenue, by End User (2017–2030)
15.4. Market Revenue, by Application (2017–2030)
Chapter 16. U.K. Market
16.1. Overview
16.2. Market Revenue, by Deployment (2017–2030)
16.3. Market Revenue, by End User (2017–2030)
16.4. Market Revenue, by Application (2017–2030)
Chapter 17. Italy Market
17.1. Overview
17.2. Market Revenue, by Deployment (2017–2030)
17.3. Market Revenue, by End User (2017–2030)
17.4. Market Revenue, by Application (2017–2030)
Chapter 18. Spain Market
18.1. Overview
18.2. Market Revenue, by Deployment (2017–2030)
18.3. Market Revenue, by End User (2017–2030)
18.4. Market Revenue, by Application (2017–2030)
Chapter 19. Japan Market
19.1. Overview
19.2. Market Revenue, by Deployment (2017–2030)
19.3. Market Revenue, by End User (2017–2030)
19.4. Market Revenue, by Application (2017–2030)
Chapter 20. China Market
20.1. Overview
20.2. Market Revenue, by Deployment (2017–2030)
20.3. Market Revenue, by End User (2017–2030)
20.4. Market Revenue, by Application (2017–2030)
Chapter 21. India Market
21.1. Overview
21.2. Market Revenue, by Deployment (2017–2030)
21.3. Market Revenue, by End User (2017–2030)
21.4. Market Revenue, by Application (2017–2030)
Chapter 22. Australia Market
22.1. Overview
22.2. Market Revenue, by Deployment (2017–2030)
22.3. Market Revenue, by End User (2017–2030)
22.4. Market Revenue, by Application (2017–2030)
Chapter 23. South Korea Market
23.1. Overview
23.2. Market Revenue, by Deployment (2017–2030)
23.3. Market Revenue, by End User (2017–2030)
23.4. Market Revenue, by Application (2017–2030)
Chapter 24. Brazil Market
24.1. Overview
24.2. Market Revenue, by Deployment (2017–2030)
24.3. Market Revenue, by End User (2017–2030)
24.4. Market Revenue, by Application (2017–2030)
Chapter 25. Mexico Market
25.1. Overview
25.2. Market Revenue, by Deployment (2017–2030)
25.3. Market Revenue, by End User (2017–2030)
25.4. Market Revenue, by Application (2017–2030)
Chapter 26. Saudi Arabia Market
26.1. Overview
26.2. Market Revenue, by Deployment (2017–2030)
26.3. Market Revenue, by End User (2017–2030)
26.4. Market Revenue, by Application (2017–2030)
Chapter 27. South Africa Market
27.1. Overview
27.2. Market Revenue, by Deployment (2017–2030)
27.3. Market Revenue, by End User (2017–2030)
27.4. Market Revenue, by Application (2017–2030)
Chapter 28. U.A.E. Market
28.1. Overview
28.2. Market Revenue, by Deployment (2017–2030)
28.3. Market Revenue, by End User (2017–2030)
28.4. Market Revenue, by Application (2017–2030)
Chapter 29. Competitive Landscape
29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments
Chapter 30. Company Profiles
30.1. Stryker Corporation
30.1.1. Business overview
30.1.2. Product and service offerings
30.1.3. Key financial summary
30.2. Zimmer Biomet Holdings Inc.
30.2.1. Business overview
30.2.2. Product and service offerings
30.2.3. Key financial summary
30.3. Medtronic Plc
30.3.1. Business overview
30.3.2. Product and service offerings
30.3.3. Key financial summary
30.4. Brainlab AG
30.4.1. Business overview
30.4.2. Product and service offerings
30.4.3. Key financial summary
30.5. mediCAD Hectec GmbH
30.5.1. Business overview
30.5.2. Product and service offerings
30.5.3. Key financial summary
30.6. 3D Systems Corporation
30.6.1. Business overview
30.6.2. Product and service offerings
30.6.3. Key financial summary
30.7. Renishaw Plc
30.7.1. Business overview
30.7.2. Product and service offerings
30.7.3. Key financial summary
Chapter 31. Appendix
31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports
| ※参考情報 術前計画ソフトウェアは、医療分野において手術を行う前に、手術の詳細な計画を立てるためのツールです。このソフトウェアは、外科医が手術を成功させるために必要な情報を集約し、視覚化する手助けをします。術前計画ソフトウェアには、さまざまな種類があり、それぞれ異なる機能や用途に特化しています。 まず、術前計画ソフトウェアの基本的な機能としては、患者の医療画像を解析することが挙げられます。CTスキャンやMRIなどの医療画像を使用して、手術対象となる部位の詳細な3Dモデルを生成することができます。これにより、外科医は具体的な手術手法や手順を視覚的に把握しやすくなります。 次に、術前計画ソフトウェアには、シミュレーション機能が組み込まれているものがあります。これにより、外科医は実際に手術を行う前に、シミュレーションを通じてさまざまなシナリオを検討できます。手術で使用する器具や手法の選択、合併症のリスクを評価する上で役立ちます。シミュレーションによって、手術の成功率を高めることが期待されています。 さらに、術前計画ソフトウェアは、患者の個別のニーズに応じたカスタマイズが可能です。たとえば、患者の年齢、性別、病歴などに基づいて、最も適切な手術計画を立てることができます。これにより、個別化医療の実現に貢献し、患者の安全性を高めることができます。 また、術前計画ソフトウェアには、手術の可視化をサポートする機能もあります。3Dモデルを使って手術エリアを可視化することで、外科医は手術中の位置関係をより明確に理解しやすくなります。これにより、手術中の迷いや不安を軽減し、迅速かつ効果的な行動が可能になります。 このように、術前計画ソフトウェアは、外科医にとって不可欠なツールとなっています。特に、脳外科や整形外科、心臓外科など、精密な手術が求められる分野では、その利用が進んでいます。術前計画ソフトウェアは、医療の質を向上させるための重要な役割を果たしています。 関連技術としては、人工知能（AI）や機械学習が挙げられます。データ解析の能力を活かして、患者の個々のデータに基づいて手術計画を最適化することができます。AIは、大量の医療データを迅速に処理し、手術後の結果を予測するモデルを構築することが可能です。この技術革新によって、外科医はより正確で効率的な手術計画を立てることができるようになります。 また、3Dプリンティング技術も関連しています。術前計画ソフトウェアで生成された3Dモデルを用いて、実際の手術に先立って身体に合わせたモデルを作成することが可能です。これにより、外科医は手術中に使用する器具やプロトタイプを早めに確認し、より具体的な手術計画を立てられます。 このように、術前計画ソフトウェアは、医療の進化に伴い、急速に発展しています。これからの医療では、術前計画ソフトウェアの利活用がますます重要になると思います。外科医が一人ひとりの患者に対して最適な治療を提供できるよう、技術や知識がさらに進化していくことが期待されます。 تر |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
